FDA Grants Approval for Polyethylene Glycol 3350 ANDA217505
The FDA has granted approval for ANDA217505, a generic formulation of Polyethylene Glycol 3350 by LNK INTL INC.
Company
LNK INTL INC
Asset
Signal assessment
Signal strength
moderate
Confidence level
moderate
Why it matters
The FDA's approval of LNK INTL INC's generic Polyethylene Glycol 3350 introduces a new competitor in the laxative market, which could disrupt pricing and market share for established brands. Portfolio teams need to evaluate the potential impact on their products and adjust strategies accordingly.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor market entry timelines and sales performance of LNK INTL INC's Polyethylene Glycol 3350.
Related companies & assets
Companies
Assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.